Veradermics, Incorporated, a dermatologist-founded, late clinical-stage biopharmaceutical company developing potentially first-in-class therapeutics for common dermatologic conditions, today announced ...
These resilient women entrepreneurs emerged from the pandemic with an enviable advantage that includes lassoing approximately $9 billion in 2024 revenue and $10.6 billion in funding. See our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback